Chief Science Officer of Genomic Prediction, Dr. Nathan Treff, presents to a packed audience at COGEN 2019 (Paris) on Expanded Preimplantation Genetic Testing (ePGT), describing Genomic Prediction's initial validation study, and the first PGT-P application to human biopsy samples.
COGEN focuses on Innovation in Preconception, Preimplantation and Prenatal Genetic Diagnosis, including:
Pre-Congress Courses on Basic Genetic Principles for the Non-Geneticists
Basic research on oocyte aging and the origin of aneuploidy
The use of Next Generation Sequencing for expanded preconception carrier screening
Novel strategies for Non-Invasive Prenatal Testing (NIPT) and Non-invasive Prenatal Diagnosis (NIPD)
The use of Whole Exome/Genome Sequencing (WES/WGS) in the evaluation of the malformed fetus
Preimplantation Genetic Testing for Aneuploidy (PGT-A) for detection of chromosome copy number abnormalities in human embryos and oocytes
Preimplantation Genetic Testing for monogenic disorders (PGT-M) and structural rearrangements (PGT-SR)
Genetic factors in implantation
The Faculty: World-renowned scientists and physicians in the field.
The COGEN Congress is a unique educational opportunity for practitioners in the field of human procreation to conduct discussions and network with leading experts. ...
Simon Fishel, Yuval Yaron & Alexandra Benachi